ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BX04 | BioTech | Romiplostim - 250mcg | 7521/388 | 186525/13 | NPLATE | 250mcg | 1 | Injectable powder for solution | SC | Mersaco | Amgen Europe BV | The Netherlands | L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BX04 | BioTech | Romiplostim - 250mcg | 7521 | 186525/13 | NPLATE | 250mcg | 1 | Injectable powder for solution | SC | Mersaco | Amgen Europe BV | The Netherlands | 67,369,332 L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 12/12/20 | 0 |